Clinical Trial Update: Intravenous (IV) Lidocaine for Opioid-refractory Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous lidocaine for opioid-refractory cancer-related pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Lidocaine (intravenous) (lidocaine)

Snippet

Sponsor: San Diego Hospice & Palliative Care | Conditions: Neoplasms, Pain | Phase 2 | Status: WITHDRAWN